[Immunomodulating activity of thymogen in acute pancreatitis].
Immunity system parameters were explored at 48 persons with diagnosis of acute pancreatitis (AP) and at 36 practically healthy persons (donors). At AP diseased were found declinations in immunity system especially at the side of immunity T-cell link. Including of tymogen in complex treatment at the dose 0.5-0.8 mg for the treatment course at AP diseased was having immune correcting action and leadind to positive dynamics of clinical changes. It was observed elimination of T-cell immune deficiency at AP diseased.
Saĭdakhmedova
Z T
ZT
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000936:Antigen-Antibody Complex / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D016516:CD4-CD8 Ratio; D004151:Dipeptides; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D010195:Pancreatitis / Q000188:drug therapy* / Q000276:immunology; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000936:Antigen-Antibody Complex; D004151:Dipeptides; D007136:Immunoglobulins; D010455:Peptides; C060736:thymogen